# A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors

> **NCT06244485** · PHASE1 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 210 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Valemetostat tosylate
- **DRUG:** T-DXd
- **DRUG:** Dato-DXd

## Key facts

- **NCT ID:** NCT06244485
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-16
- **Primary completion:** 2028-11-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06244485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06244485, "A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06244485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*